FDA Approved Products

6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.

Type:AllNDABLAANDA
Lifecycle:GrowthPeakLOE ApproachingPost-LOELaunchPre-Launch
Sort:Approval DateNameCompetitive Pressure↓
INDOCIN SR
indomethacin
LOE Approaching
ORAL · CAPSULE, EXTENDED RELEASE
1982
NDA
30/100
INDOMETHACIN
indomethacin
LOE Approaching
ORAL · CAPSULE
1984
NDA
30/100
INDOMETHACIN
indomethacin
LOE Approaching
Charter Medical
ORAL · CAPSULE
1984
NDA
30/100
INDOMETHACIN
indomethacin
LOE Approaching
Fresenius Kabi
INJECTION · INJECTABLE
2010
NDA
30/100
INDOMETHACIN
indomethacin
LOE Approaching
Teva
ORAL · CAPSULE
1984
NDA
30/100
INDOMETHACIN
indomethacin
LOE Approaching
Molecular Devices
ORAL · CAPSULE
1984
NDA
30/100
INFANT'S ADVIL
ibuprofen
LOE Approaching
GSK
ORAL · SUSPENSION/DROPS
1998
SMNDA
30/100
INFANTS' FEVERALL
acetaminophen
LOE Approaching
RECTAL · SUPPOSITORY
1980
NDA
30/100
INFED
iron dextran
LOE Approaching
AbbVie
INJECTION · INJECTABLE
older with documented iron deficiencyan unsatisfactory response to oral iron
1974
NDA
30/100
INFUVITE ADULT
multiple vitamins injection
LOE Approaching
Novartis
INTRAVENOUS · SOLUTION
vitamin deficiency in adultschildren aged 11+1
2000
NDA
30/100
INFUVITE PEDIATRIC
multiple vitamins injection
LOE Approaching
Novartis
INTRAVENOUS · INJECTABLE
vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition ()
2001
NDA
30/100
INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE)
multiple vitamins injection
LOE Approaching
Novartis
INTRAVENOUS · INJECTABLE
vitamin deficiency in pediatric patients up to 11 years of age receiving parenteral nutrition ()
2001
NDA
30/100
INNOHEP
tinzaparin sodium
LOE Approaching
Leo Pharma
INJECTION · INJECTABLE
2000
NDA
30/100
INNOPRAN XL
propranolol hydrochloride
LOE Approaching
ANI Pharmaceuticals
ORAL · CAPSULE, EXTENDED RELEASE
hypertensionto lower blood pressure
2003
NDA
30/100
INOCOR
inamrinone lactate
LOE Approaching
Sanofi
INJECTION · INJECTABLE
1984
NDA
30/100
INPERSOL-ZM W/ DEXTROSE 1.5% IN PLASTIC CONTAINER
calcium chloride; dextrose; sodium chloride; sodium lactate
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
1986
NDA
30/100
INPERSOL-ZM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
calcium chloride; dextrose; sodium chloride; sodium lactate
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
1986
NDA
30/100
INPERSOL-ZM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
calcium chloride; dextrose; sodium chloride; sodium lactate
LOE Approaching
Fresenius Kabi
INTRAPERITONEAL · SOLUTION
1986
NDA
30/100
INSPRA
eplerenone
LOE Approaching
Viatris (2)
ORAL · TABLET
2002
NDA
30/100
INTAL
cromolyn sodium
LOE Approaching
Pfizer
INHALATION · SOLUTION
1982
NDA
30/100
INTAL
cromolyn sodium
LOE Approaching
Pfizer
INHALATION · AEROSOL, METERED
1985
NDA
30/100
INTEGRILIN
eptifibatide
LOE Approaching
Merck & Co.
INJECTION · INJECTABLE
1998
PeptideNDA
30/100
INTELENCE
etravirine
LOE Approaching
Johnson & Johnson
ORAL · TABLET
2008
NDA
30/100
INTRALIPID 10%
i.v. fat emulsion
LOE Approaching
Fresenius Kabi
INJECTION · INJECTABLE
1975
NDA
30/100
← PreviousPage 87 of 277Next →